Starting with mythics, this week Sylvain discusses which cards from M14 and Return to Ravnica may constitute a good investment after Standard rotates.
Tibalt, the Fiend-Blooded
Planeswalkers present a unique opportunity to the trader with the right outs available. Today Jason Alt outlines a specific trading strategy involving the iconic card type.
Last week Jason Alt walked through the easy way to out bulk. Today he discusses some more time-intensive options that yield much higher profits.
Matthew Lewis looks at the planeswalkers about to rotate and asks what past experience tells us about their likely price trajectories.
Matthew Lewis presents his review of each mythic rare from M14. Which cards are Fully Priced, Borderline or Good Value?
Jared Elick surveys the current value of several planeswalkers and predicts whether they’re on the rise or declining.
Matthew Lewis outlines a method for squeezing out a little extra value from those last couple tickets you have lying around.
As Return to Ravnica spoilers continue, a variety of questions arise. With this incredibly popular, highly anticipated set, what are the solid buys? Are there some cards that may gain in value thanks to RtR? Should you buy a booster box now or wait until release? Are there any cards worth preordering? Sigmund touches on all these topics in this week’s article.
Mark reviews the full spoiler of M13 and analyzes its impact on Standard. What cards will we no longer have after rotation? And what their replacements, if any?
Join Mike as he relates his experiences this PTQ season. In the first PTQ he narrowly misses top eight with an innovative list that aims to ramp into Frost Titan.
Avacyn Restored offers many new tools for the enterprising Commander brewer. Carlos begins by matching up Tibalt, the Fiend-Blooded with an old favorite: Squee!
Sigmund explores preordering and which cards you should pick up at their current bargain prices.